The United Laboratories International Holdings Limited provided earnings guidance for the six months ended 30 June 2013. For the period, the group's unaudited interim results are expected to record a substantial decrease in profit as compared with comparative period in 2012. The decrease in profit is mainly attributable to decrease in fair value of embedded derivative components of convertible bonds and written off of certain plant facilities located in Chengdu factory upon recent relocation plan in order to streamline the production, both of which are non-cash items having no impact to the group's liquidity position.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 HKD | -0.98% | +0.74% | +15.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.83% | 1.91B | |
+61.53% | 856B | |
+38.95% | 631B | |
-3.66% | 359B | |
+15.06% | 325B | |
+9.18% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.67% | 177B | |
+2.47% | 165B |
- Stock Market
- Equities
- 3933 Stock
- News The United Laboratories International Holdings Limited
- The United Laboratories International Holdings Limited Provides Earnings Guidance for the Six Months Ended 30 June 2013